Aspire Biopharma Holdings, Inc. (ASBPW) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
ASBPW Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Aspire Biopharma Holdings, Inc. (ASBPW) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.02 and trailing twelve-month earnings per share of $-0.64.
Compared to the Healthcare sector median P/E of 22.3x, ASBPW trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, ASBPW trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ASBPW DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ASBPW P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 14.4Lowest | 3.85 | -29% | |
| $195M | 164.4 | - | +102%Best | |
| $391M | 28.8 | 0.86Best | +51% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See ASBPW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASBPW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASBPW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASBPW — Frequently Asked Questions
Quick answers to the most common questions about buying ASBPW stock.
Is ASBPW stock overvalued or undervalued?
ASBPW current P/E: -0.0x. 5-year average P/E: N/A. Percentile: N/A.
How does ASBPW's valuation compare to peers?
Aspire Biopharma Holdings, Inc. P/E of -0.0x compares to sector median of 22.3x. Sector comparison provides relative valuation context.
What is ASBPW's PEG ratio?
ASBPW PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.